Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prednisolone starting-dose comparison in early active rheumatoid arthritis
2012-004074-25Phase 3Completed
- Sponsor
- Ruhr University Bochum
- Start
- Jul 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of prednisolone and methotrexate in rheumatoid arthritis (RA) (3 arms), sponsored by Ruhr University Bochum. Primary endpoint: Progression of radiographic damage after one year. Started Jul 2013; status: completed.
02
Drugs
prednisolonemethotrexate
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2012-004074-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-004074-25.